Skip to main content
Shandong Wohua Pharmaceutical Co., Ltd. logo

Shandong Wohua Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002107 ISIN · CNE000001QB8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,202 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002107

About Shandong Wohua Pharmaceutical Co., Ltd.

https://www.wohua.cn

Shandong Wohua Pharmaceutical Co., Ltd. is a pharmaceutical enterprise specializing in the research, development, production, and marketing of Traditional Chinese Medicine (TCM). The company traces its heritage back to the Wansheng Hall, established during the Qing Dynasty. Its core product portfolio focuses on cardiovascular, cerebrovascular, and orthopedic therapeutic areas. Key products include Wohua Xinkang, a proprietary TCM formulation used for treating coronary heart disease and angina pectoris, and Jiegu Qishi, utilized in bone fracture recovery. The company emphasizes the modernization of traditional prescriptions through advanced extraction and manufacturing processes. Its operations integrate a complete value chain from raw material sourcing to clinical research and distribution, aiming to provide standardized and evidence-based TCM solutions for chronic disease management.

Recent filings

Filing Released Lang Actions
关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 85% confidence The document is a public announcement by the company about its participation in an online investor reception day organized by regulators and investor associations. It does not contain financial statements, voting results, dividends, or detailed presentations—it merely informs investors of an upcoming virtual event for Q&A. There is no formal report attached, nor substantive financial data or proxy materials. This type of general regulatory announcement falls under the fallback category “Regulatory Filings” (RNS).
2026-05-12 Chinese
关于董事减持公司股份的预披露公告
Director's Dealing Classification · 100% confidence The document is a pre-disclosure announcement regarding a planned reduction in shareholding by a company director, specifically the board secretary Zhang Ge. It details the number of shares held, the planned reduction amount, the method of reduction, the timing, and compliance with relevant regulations. There is no financial data, earnings information, or report content. The document is a notification of a director's personal share transactions (share reduction). This fits the category of Director's Dealing (DIRS). The document length is short and focused solely on the director's shareholding change, confirming it is not a full report or announcement of a report publication.
2026-05-07 Chinese
第八届董事会第八次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Shandong Wohua Pharmaceutical Technology Co., Ltd. It details the decisions made at the eighth board meeting, including approval of the company's 2026 first quarter report, a remuneration management system for directors and senior management, and the scheduling of an extraordinary shareholders meeting. The document does not contain the actual quarterly report or financial data but references that the report is published on an external website. The document is short (1017 characters) and serves as an announcement of board decisions and meeting resolutions rather than a full financial report or detailed management discussion. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting resolutions and management-related decisions.
2026-04-07 Chinese
山东沃华医药科技股份有限公司关于召开2026年第一次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2026 first extraordinary general meeting (临时股东会) of shareholders for 山东沃华医药科技股份有限公司. It includes details about the meeting time, location, voting procedures, registration, and agenda items. It does not contain financial statements or results but is an announcement of a shareholders meeting. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is not a full report, earnings release, or regulatory filing but a meeting notice with voting instructions.
2026-04-07 Chinese
2026年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2026年第一季度报告' which translates to '2026 First Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the first quarter of 2026. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the quarter. It also mentions that the report is unaudited, which is typical for interim or quarterly reports. The length of the document (over 12,000 characters) and the presence of substantive financial data confirm it is the actual report, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-07 Chinese
2025年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2025 annual dividend distribution plan approved at the 2026 shareholders' meeting. It details the dividend amount per share, the record date, the ex-dividend date, the dividend payment method, and related shareholder information. There is no financial statement or comprehensive report content, only the dividend distribution details. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders. The document length is short (2038 characters), and it is not a report publication announcement or regulatory filing. Therefore, the correct classification is DIV.
2026-02-26 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.